Brief: Enorama Pharma Q4 Operating Loss Widens TO SEK 26.7 Mln
19/02/2025 07:31
Feb 19 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q4 NET SALES AMOUNTED TO 2 641 (7 481) KSEK
* Q4 OPERATING RESULT AMOUNTED TO -26 673 (-4 476) KSEK
Source text: ID:nWkr7FhzCv
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO